PEPTIDEAmericas
EN/ES
Back to resultsEspañol
Descriptive combination
Conceptual educational illustration of Tesamorelin / Tesamorelina in a glass vial, labelled MOLECULE PROFILE.

Tesamorelin / Tesamorelina

View full illustrationSave Tesamorelin / Tesamorelina

Conceptual educational illustration of Ipamorelin / Ipamorelina in a glass vial, labelled MOLECULE PROFILE.

Ipamorelin / Ipamorelina

View full illustrationSave Ipamorelin / Ipamorelina

COMBINATION PROFILE

Tesamorelin + ipamorelin

Sources checked · October 16, 2026

Published for review · Scientific, medical, translation and citation review pending. Reported uses are not authorized indications. Frequency reflects mentions in supplied sources, not sales or global clinical prevalence.

Components

Community claim

Visceral-fat and growth-hormone claims.

Community and market provenance

Community mention, not clinical evidence

  • Source: pdf01 · Page 6
  • Source: pdf04 · Page 6
  • Source: pdf05 · Page 6
  • Source: pdf08 · Page 6
  • Source: pdf09 · Page 3
  • Source: img06 · Page 1

Evidence of the exact combination

No controlled clinical validation of this exact marketed combination was established in this review. Ingredient evidence is not combination evidence.

Component links are not combination evidence. A commercial name’s composition may vary.

Uncertainty and risks

Tesamorelin HIV indication is not approval of this combination; additive GH/IGF-1 and glycemic effects require study.

Observed in supplier/community material; prevalence not quantified.

No dosing or mixing instructions are provided.

Source issues and references

References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.

  1. R06

    FDA: current bulk-substance safety-risk page

  2. R12

    Beck et al.: ipamorelin postoperative ileus trial, 2014

    DOI: 10.1007/s00384-014-2030-8PMID: 25331030
  3. R13

    EGRIFTA WR prescribing information, revised March 2025

  4. pdf01

    PEPNEXA 2.pdf

    October 16, 2026

  5. pdf05

    PEPNEXA.pdf

    October 16, 2026

  6. pdf09

    PeptideFactory.pdf

    October 16, 2026

A community-based bilingual scientific education initiative for healthcare professionals and the general public across the Americas.Currently self-funded; no current sponsors. Formal governance and legal documentation pending.info@peptideamericas.org · Planned contact address — not active yet; please do not send messages.